Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Heart and Vascular Center, Dartmouth-Hitchcock Medical Center.
Curr Opin Cardiol. 2024 May 1;39(3):218-225. doi: 10.1097/HCO.0000000000001120. Epub 2024 Mar 13.
Heart failure (HF) is characterized by significant symptoms, compromised quality of life, frequent hospital admissions, and high mortality, and is therefore well suited to palliative care (PC) intervention. This review elaborates the current PC needs of patients with HF across the spectrum of disease, including patients who undergo advanced HF surgical therapies, and reviews the current data and future directions for PC integration in HF care.
Patients with chronic HF, as well as those who are being evaluated for or who have undergone advanced HF surgical therapies such as left ventricular assist device or heart transplantation, have a number of PC needs, including decision-making, symptoms and quality of life, caregiver support, and end-of-life care. Available data primarily supports the use of PC interventions in chronic HF to improve quality of life and symptoms. PC skills and teams may also help address preparedness planning, adverse events, and psychosocial barriers in patients who have had HF surgeries, but more data are needed to determine association with outcomes.
Patients with HF have tremendous PC needs across the spectrum of disease. Despite this, more data are needed to determine the optimal timing and structure of PC interventions in patients with chronic HF, left ventricular assist device, and heart transplantation. Future steps must be taken in clinical, research, and policy domains in order to optimize care.
心力衰竭(HF)的特点是症状明显、生活质量受损、频繁住院和死亡率高,因此非常适合姑息治疗(PC)干预。本综述阐述了 HF 患者在疾病谱中的 PC 需求,包括接受先进 HF 手术治疗的患者,并回顾了 PC 在 HF 治疗中的整合的现有数据和未来方向。
慢性 HF 患者以及正在接受评估或接受左心室辅助装置或心脏移植等先进 HF 手术治疗的患者有许多 PC 需求,包括决策、症状和生活质量、照顾者支持和临终关怀。现有数据主要支持在慢性 HF 中使用 PC 干预措施来改善生活质量和症状。PC 技能和团队也可能有助于解决接受 HF 手术后患者的准备计划、不良事件和心理社会障碍,但需要更多的数据来确定与结果的关联。
HF 患者在疾病谱中存在巨大的 PC 需求。尽管如此,仍需要更多的数据来确定慢性 HF、左心室辅助装置和心脏移植患者中 PC 干预的最佳时机和结构。为了优化治疗,必须在临床、研究和政策领域采取未来的步骤。